1. Home
  2. GROW vs INKT Comparison

GROW vs INKT Comparison

Compare GROW & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • INKT
  • Stock Information
  • Founded
  • GROW 1968
  • INKT 2017
  • Country
  • GROW United States
  • INKT United States
  • Employees
  • GROW N/A
  • INKT N/A
  • Industry
  • GROW Investment Managers
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • GROW Finance
  • INKT Health Care
  • Exchange
  • GROW Nasdaq
  • INKT Nasdaq
  • Market Cap
  • GROW 32.9M
  • INKT 43.0M
  • IPO Year
  • GROW N/A
  • INKT 2021
  • Fundamental
  • Price
  • GROW $2.46
  • INKT $11.00
  • Analyst Decision
  • GROW
  • INKT Strong Buy
  • Analyst Count
  • GROW 0
  • INKT 2
  • Target Price
  • GROW N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • GROW 30.9K
  • INKT 71.7K
  • Earning Date
  • GROW 02-12-2025
  • INKT 03-20-2025
  • Dividend Yield
  • GROW 3.67%
  • INKT N/A
  • EPS Growth
  • GROW N/A
  • INKT N/A
  • EPS
  • GROW 0.12
  • INKT N/A
  • Revenue
  • GROW $10,008,000.00
  • INKT N/A
  • Revenue This Year
  • GROW N/A
  • INKT N/A
  • Revenue Next Year
  • GROW N/A
  • INKT N/A
  • P/E Ratio
  • GROW $20.22
  • INKT N/A
  • Revenue Growth
  • GROW N/A
  • INKT N/A
  • 52 Week Low
  • GROW $2.38
  • INKT $4.56
  • 52 Week High
  • GROW $2.95
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • GROW 54.17
  • INKT 59.75
  • Support Level
  • GROW $2.43
  • INKT $7.32
  • Resistance Level
  • GROW $2.48
  • INKT $13.79
  • Average True Range (ATR)
  • GROW 0.04
  • INKT 2.07
  • MACD
  • GROW 0.00
  • INKT 0.28
  • Stochastic Oscillator
  • GROW 60.00
  • INKT 71.94

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: